argenx
AD, HCP Marketing
Boston, MA | $118K - $149K
- 501-1,000 employees
- Biotechnology, Medical, Therapeutics, Pharmaceuticals, Healthcare, Biopharmaceuticals, Medical Research & Development, Drug Manufacturers, Medical Research & Laboratories
- Public Company
- Last round: Aug 19, 2023
- Last round: US$ 1.1B
- Boston, MA
- Company Specialties:
Oncology, Autoimmune diseases, Rare Diseases, Antibody based medicines, Immunotherapy, Myasthenia Gravis, Immunology, Pemphigus Vulgaris, Immune Thrombocytopenia, Acute Myeloid Leukemia , high-risk myelodysplastic syndromes, and chronic inflammatory demyelinating polyneuropathy
Company information
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
